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Four broad-spectrum, 11 and 12 residue, novel antimi-
crobial peptides have been isolated from the adrenaline-
stimulated skin secretions of the Indian frog Rana tige-
rina. Sequences of these peptides have been determined
by automated Edman degradation, by mass spectral
analysis and confirmed by chemical synthesis. These
peptides, which we have named as tigerinins, are char-
acterized by an intramolecular disulfide bridge between
two cysteine residues forming a nonapeptide ring. This
feature is not found in other amphibian peptides. Con-
formational analysis indicate that the peptides tend to
form b-turn structures. The peptides are cationic and
exert their activity by permeabilizing bacterial mem-
branes. Tigerinins represent the smallest, nonhelical,
cationic antimicrobial peptides from amphibians.
Antimicrobial peptides constitute a very important compo-
nent of the innate immune system in organisms across the
evolutionary scale (1–8). Amphibians being the first group of
organisms forming a connecting link between land and water
are forced to adopt and survive in a variety of conditions laden
with pathogenic microbes. Thereby, they are endowed with an
excellent chemical defense system composed of pharmacologi-
cal and antimicrobial peptides (9). Bombinins were the first
antimicrobial peptides characterized from the skin of Bombina
variegata in 1969 (10). The discovery of magainins from the
skin secretions of Xenopus laevis in 1987 (11) triggered exten-
sive search and characterization of antimicrobial peptides from
amphibians (12–14). Antimicrobial peptides from genus Rana
share an interesting structural motif composed of a disulfide-
bridged cationic heptapeptide segment at the COOH-terminal
end. Peptides with this motif include brevinins and esculentins
which are composed of 24 and 46 amino acids, respectively (14).
The primary structures of large number of peptides belonging
to this family have been determined. Another group of short
peptides composed of 13 residues called temporins, which do
not contain this COOH-terminal ring, have also been charac-
terized from frogs of genus Rana (15). However, considering the
large variety of amphibian species in nature, antimicrobial
peptides from only a small number of them have been charac-
terized, that too only with respect to primary structure. Also,
studies directed toward determining structure-function rela-
tionships have been confined to magainins (16) and dermasep-
tins (17, 18). Hence, characterizing host-defense peptides from
other species would be of interest and could conceivably result
in the identification of new structural motifs which would be
useful in designing peptides for therapeutic applications. Rana
tigerina is the predominant species of frogs found in India (19).
The skin of these frogs have been used traditionally by some
tribal communities to heal both open and burn wounds and the
antimicrobial components could possibly contribute to the
wound healing process (20). In this study, we have described
the isolation and characterization of antimicrobial peptides
from R. tigerina. These peptides are composed of only ;11–12
residues that do not have primary structural homology to any
of the known antimicrobial peptides derived from amphibians.
They are characterized by a disulfide-bridged loop composed of
9 amino acids. We have named these peptides as tigerinins.
EXPERIMENTAL PROCEDURES
Collection of Skin Secretions
The frogs of the species (R. tigerina) were stimulated to release
peptides through adrenergic-mediated granular gland secretion by in-
jecting 0.5 ml of 1 mM adrenaline (Loba Chemie) into the dorsal sacs.
The secretions were collected from the dorsal surface in ethanol:water
(3:1, v/v) and subsequently dried under reduced pressure so as to
remove ethanol and redispersed in water acidified with 0.1% trifluoro-
acetic acid. Solid phase extraction on reverse phase (C18) was carried
out with the clarified homogenate which involved the pumping of the
extract through eight Sep-Pak C18 cartridges (Waters Associates) con-
nected in series at a flow rate of 1 ml/min. Bound material was sequen-
tially eluted with 15, 30, and 60% of acetonitrile in acidified water and
freeze dried. These fractions were evaluated for antimicrobial activity.
Purification of the Peptides
The frog skin secretions obtained after partial purification on Sep-
Pak cartridges were redissolved in acidified water (HPLC1 pure) and
purified further on an analytical reverse-phase Water’s mBondapak C18
column equilibrated with 0.1% (v/v) trifluoroacetic acid/water at a flow
rate of 1 ml/min. The acetonitrile concentration in the eluting solvent
was raised from 0 to 40% in 30 min and from 40% to 100% in 5 min.
Fractions were collected according to detection at 210 nm and dried in
a vacuum centrifuge and evaluated for antimicrobial activity.
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Peptide Characterization
HPLC purified active peptide fractions were subjected to amino-
terminal sequence analysis using a 473 A Applied Biosystems gas phase
sequencer. Cysteine residues were identified by the alkylation of the
HPLC purified active peptide fractions redispersed in pyridine buffer
(pH 8.3) with iodoacetamide incubated in dark for 1 h at 37 °C. Prior to
treatment with iodoacetamide, dithiothreitol was added at a concentra-
tion of 10-fold molar excess over expected disulfides and nitrogen was
flushed to provide an inert atmosphere throughout the reaction (21).
The reaction was terminated by using b2mercaptoethanol at a concen-
tration of 10-fold excess to that of the peptide. The alkylated peptides
were desalted, run on reverse phase C18 column and were subsequently
characterized by protein sequencing and mass spectrometry. Alkylation
with iodoacetamide without prior reduction with dithiothreitol was also
carried out to ascertain the presence of disulfide bridges.
Mass Spectrometry
The HPLC purified active peptide fractions as well as iodoacetamide-
treated fractions were acidified with 0.1% trifluoroacetic acid in water
and mixed with a-cyano-4-hydroxycinnamic acid matrix and loaded on
a stainless steel target and the molecular weights were determined
using matrix-assisted laser desorption/ionization time of flight mass
spectrometry (Kratos PC-Kompact MALDI 4VI.1.2).
COOH-terminal Analysis
The status of the carboxyl terminus was investigated by digestion of
the natural peptides with carboxypeptidase Y that was pretreated with
phenylmethylsulfonyl fluoride to inactivate endopeptidase and amidase
activities (22). Aliquots of the enzyme digests were taken at 1- and 2-h
time points and were subjected to amino acid analysis (LKB 4151 Alpha
Plus Amino acid Analyzer).
Peptide Synthesis
Peptides identified were synthesized manually on amide crowns
(Chiron technologies) by the solid phase method using Fmoc chemistry
(23). All amino acids were added as Fmoc hydroxy benzotriazole active
esters. The peptides were cleaved from the resin by treatment with
trifluoroacetic acid/thioanisole/phenol/water/ethanedithiol (16.5:1:1:1:
0.5, v/v) overnight at room temperature. The peptides were checked for
purity on HPLC using a reverse phase column (Waters mBondapak C18)
using a solvent system of 0.1% aqueous trifluoroacetic acid and
acetonitrile. The cysteines were deprotected with mercury (II) acetate
in the ratio of 2 equivalents for each equivalent of cysteine. Mercuric
FIG. 1. Reverse-phase HPLC of skin secretions of R. tigerina.
Analysis of adrenergic-mediated skin secretions of R. tigerina eluting
between 15 and 30% acetonitrile concentration through Sep-Pak car-
tridges on a C18 mBondapak column. Conditions: Solvent A, 0.1% trif-
luoroacetic acid in water; B, 0.1% trifluoroacetic acid in acetonitrile;
gradient of 0–40% B in 30 min and 40% to 100% in 5 min at a flow rate
of 1 ml/min. Detection was at 210 nm.
FIG. 2. Mass spectroscopic analysis
of peptides. A-C are the mass spectra of
the peaks obtained by HPLC with reten-
tion times 21.57, 23.40, and 24.10 min,
respectively. D-F, correspond to mass
spectra of the peptides in A-C after treat-
ment with iodoacetamide and purified on
HPLC.
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sulfide salts formed were precipitated with 20 eq of b-mercaptoethanol
(24). The peptides were then desalted and the disulfide bridges were
formed with 20% dimethyl sulfoxide (25). The synthesized peptides
were run on C18 reverse phase HPLC column independently as well as
mixing with natural peptide fractions. The synthetic peptides were then
used for evaluating antimicrobial activity.
Antimicrobial Activity
Minimal inhibitory concentration of the crude 15, 30, and 60% frac-
tions was monitored by the decrease in turbidity at 600 nm of Esche-
richia coli W160.37 cells grown to logarithmic phase in minimal A
medium (10.5 g of KH2PO4, 4.5 g of K2HPO4, 1 g of [NH4]2SO4, 0.5 g of
sodium citrate, 0.1 mM magnesium sulfate, 0.1 g of L-arginine, and 1%
glucose in 1 liter of water) (26).
For evaluating antimicrobial activity of the purified peptides, liquid
culture assays were carried out wherein varying concentrations of the
peptides were added to 100 ml of suspension of the organisms diluted
from a midlogarithmic phase liquid culture to a concentration of 105
cells/ml in sodium phosphate buffer (27, 28). The microbicidal activity
was determined by counting the number of viable colony forming units
on nutrient agar plates after 2 h of incubation with the individual
peptides. The microorganisms used were Pseudomonas putida, Micro-
coccus luteus, Bacillus subtilis, Staphylococcus aureus, E. coli, and
Saccharomyces cerevisiae. The kinetics of killing was also evaluated for
E. coli and S. aureus by determining the viable cell counts as a function
of time.
Outer Membrane Permeability
Outer membrane permeability was assessed by N-phenyl-1-N-naph-
thylamine (NPN, Sigma) uptake assay (29). E. coli W160-37 cells were
grown to late logarithmic phase in bactonutrient broth (Himedia) and
the cells obtained were washed twice with 5 mM HEPES buffer (pH 7.4).
A 1-ml aliquot of cells so prepared, adjusted to an A600 of 0.5 in the same
buffer containing 10 mM NPN was taken for each experiment. The
excitation monochromator was set at 350 nm and the emission at 420
nm was continuously monitored after the addition of the peptide from
an aqueous stock solution.
Inner Membrane Permeability
Inner membrane permeability was monitored by the o-nitrophenyl-
3-D-galactoside (ONPG) influx as described by Lehrer et al. (30). In
brief, E. coli W160-37 cells were grown to late logarithmic phase in
bactonutrient broth (Himedia) in the presence of 5 3 1024 M isopropyl
thiogalactoside for inducing the cytoplasmic enzyme b-galactosidase.
The culture was then diluted to an A600 of 0.03 with 10 mM sodium
phosphate buffer (pH 7.4) containing ONPG that serves as a substrate.
Aliquots of this were incubated with peptides at 37 °C and the influx of
ONPG into the cells was monitored by absorbance measurements at
420 and 550 nm at fixed time intervals. ONPG influx into the cells
recorded as (A420 2 1.75 3 A550) reflects the permeability status of inner
FIG. 3. Kinetics of killing of bacte-
ria by tigerinins. A-C, S. aureus; D-F, E.
coli. Cells in the midlogarithmic phase of
growth (105 colony forming units) were
incubated with different concentrations of
tigerinins (A and D, 10 mg/ml; B and E, 20
mg/ml, and C and F, 30 mg/ml) and ali-
quots were drawn out at different inter-
vals after incubation and were plated on
nutrient broth. The number of colonies
developed were counted after incubating
the plates for 18 h at 37 °C. Open square,
tigerinin 1; open triangle, tigerinin 2;
open circle, tigerinin 3; cross, tigerinin 4.
Cells incubated in the absence of any pep-
tide served as controls.
TABLE I
Sequences of antimicrobial peptides from R. tigerina
Am, COOH-terminal amide. All the cysteine residues in tigerinins
are linked by intramolecular disulfide bridge.
Peptide Sequence
Tigerinin 1 FCTMIPIPRCY-Am
Tigerinin 2 RVCFAIPLPICH-Am
Tigerinin 3 RVCYAIPLPICY-Am
Tigerinin 4 RVCYAIPLPIC-Am
TABLE II
Antimicrobial activity of Tigerinins
Microorganisms
MIC
Tigerinin 1 Tigerinin 2 Tigerinin 3 Tigerinin 4
mg/ml
B. subtilis 30 20 30 NTa
S. aureus (ATCC 8530) 30 40 30 50
E. coli (W 160.37) 40 50 40 60
P. putida (NCIM 2102) 40 50 40 60
M. luteus (MT 166) 20 20 30 NT
S. cerevisiae (ATCC 8530) 80 100 80 100
a NT, not tested.
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membrane. ONPG influx was monitored also in the presence of divalent
cation, calcium.
Hemolytic Activity
Hemolytic activities of the peptides were evaluated essentially as
described earlier (31), using rat erythrocytes isolated from heparinized
blood by centrifugation. The cells were washed three times with 5 mM
HEPES buffer containing 150 mM sodium chloride. Aliquots of 1-ml
suspension containing 107 cells in Eppendorf tubes were incubated with
different concentrations of peptides in duplicates at 37 °C for 30 min
with gentle mixing. The tubes were then centrifuged and absorbance of
the supernatants was measured at 540 nm. The lysis obtained with
water was considered as 100%.
Conformational analysis
Circular Dichroism (CD) Studies—CD spectra of the peptides were
recorded in 5 mM HEPES buffer (pH 7.4) in a JASCO J-715 spectropo-
larimeter in 0.1-cm path-length cells at 25 °C. Calibration was carried
out with d10-camphor sulfonic acid. CD band intensities are represented
as mean residue ellipticity.
Theoretical Studies—The starting structures were generated in ex-
tended conformation with f,c 5 2180o for nonproline residues and
f,c 5 275o, 2180o for prolines using BIOPOLYMER module of MSI of
version 98. The cysteines were bonded to form a disulfide bridge. These
structures were minimized for a short duration to remove bad contacts.
The structures were then optimized using a combination of minimizers
like Steepest Descent, Conjugate Gradient, and Newton Raphson’s
methods for 3000 iterations till a final convergence of 0.001 was
achieved. The Amber force field “amber.frc” provided in the MSI 98
(Biosym technologies, San Diego) was used for all calculations. The final
structures were equilibrated for 10 ps duration before they were sub-
jected to dynamics of 500 ps at a constant temperature of 298 K using
a NVT ensemble temperature control method. The velocity-verlet inte-
gration method was used in this case. The final structures were once
again minimized for 3000 iterations to achieve a convergence of 0.001.
The optimization and Molecular Dynamics (MD) studies were con-
ducted by using DISCOVER module provided in MSI 98. The dihedral
angles for the final structures were calculated by using STRIDE soft-
ware program developed by Patrick Argos of EMBL (32). The Procheck
Program indicated that all the dihedral angles were in the allowed
regions in the Ramachandran map.
RESULTS
Characterization of Peptides—The lyophilized material ob-
tained from the adrenaline-stimulated skin secretions or the
skin extracts of R. tigerina was initially processed on Sep-Pak
cartridges. The fraction that eluted between 15 and 30% ace-
tonitrile contained all the antimicrobial activity against E. coli.
This fraction was subjected to further fractionation on a
mBondapak C18 column. A chromatogram obtained is shown in
Fig. 1. The peaks eluting at 21.57, 23.40, and 24.10 min exhib-
ited antimicrobial activity against E. coli. Mass spectral anal-
ysis yielded mass values of 1342, 1368, and 1409, respectively
(Fig. 2, A-C). Amino acid sequence analysis indicated the
sequences as F_TMIPIPR_Y, RV_FAIPLPI_H, and RV_
YAIPLPI_Y. To determine whether the gaps in the sequences
could arise due to the presence of cysteine residues, the pep-
tides were alkylated with iodoacetamide, purified on HPLC,
and subjected to mass spectral analysis. The data shown in Fig.
2, D-F, indicate mass increases which correspond to the alky-
lation of two cysteine residues. When sequencing of the modi-
fied peptides were carried out, the alkylated cysteine residues
eluted at the blank positions observed for unmodified cysteines.
We have named these peptides as tigerinins. Treatment of
tigerinins with carboxypeptidase Y did not result in the release
of free amino acids under conditions where free amino acids
were released from peptides with free COOH-terminal COOH
groups, indicating that the COOH-terminal ends of tigerinins
1, 2, and 3 were amidated. The peptides on alkylation with
iodoacetamide, without prior reduction with dithiothreitol, did
not yield the alkylated derivatives of cysteine indicating that
the two cysteine residues were linked by a disulfide bridge. The
sequences of the peptides were further confirmed by chemical
synthesis. The synthetic peptides coeluted with their natural
counterparts on HPLC and exhibited identical mass values.
Reproducible HPLC profiles were obtained with different
batches of skin secretions. When the skin extracts were pro-
cessed using similar protocols, along with the other three pep-
tides an additional peptide, which coeluted with tigerinin 3,
with a mass of 1247 was obtained. On treatment with iodoac-
etamide, this peptide could be separated from tigerinin 3. On
the basis of sequence and mass spectral analysis, the primary
structure of this peptide is RVCYAIPLPIC-amide. The primary
structures of the peptides are summarized in Table I.
Antimicrobial Activity—The minimal inhibitory concentra-
tions of the natural tigerinins are shown in Table II. All the
peptides exhibit activities against Gram-positive and Gram-
negative bacteria as well as yeast with minimal inhibitory
concentrations varying between 30 and 100 mg/ml. The bacte-
ricidal activity of tigerinins was investigated by studying the
FIG. 4. Peptide-mediated NPN uptake in E. coli W 160.37. E. coli
cells were incubated with NPN in the presence of various concentra-
tions of tigerinins. Enhanced uptake was measured by an increase in
fluorescence caused by partition of NPN in to hydrophobic interior of
the OM. Open square, tigerinin 1; open triangle, tigerinin 2; open circle,
tigerinin 3; cross, tigerinin 4; filled square, linear analog of tigerinin 1,
tigerinin 1(cys-Acm).
FIG. 5. Effect of tigerinins on the influx of ONPG in E. coli W
160.37. E. coli cells in the logarithimic phase of growth were diluted to
a A600 of 0.03 in phosphate buffer containing ONPG and incubated at
37 °C with the peptides (40 mg/ml). The absorption at 420 and 550 nm
were recorded at various time points. The value of (A420 2 1.75 3 A550)
was taken to denote ONPG influx. Panel A: open square, tigerinin 1;
open triangle, tigerinin 2; open circle, tigerinin 3; cross, tigerinin 4;
diamond, control without any peptide. Panel B: open triangle, tigerinin
2; filled triangle, tigerinin 2 in the presence of 600 mM Ca21; diamond,
control without peptide.
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kinetics of killing of two representative organisms, E. coli and
S. aureus. The results are shown in Fig. 3. In the first 5 min of
incubation itself, between 60 and 80% of cells are killed in the
case of all the peptides, even at the lowest concentration of 10
mg/ml. Complete killing is seen between 30 and 120 min. While
tigerinin 1 is the most active peptide for S. aureus, tigerinin 2
is the most active on E. coli. All the peptides are bactericidal
and killing is rapid.
The rapid killing of microbial cells by cationic peptides is
generally mediated by membrane permeabilization (1–8) and
hence the ability of tigerinins to permeabilize the bacterial
membranes was examined. The extent to which E. coli OM
becomes permeable to NPN in the presence of tigerinins is
shown in Fig. 4. Tigerinin 1 is most effective in permeabilizing
the OM of E. coli and tigerinin 2 and 3 are marginally less
active with 50% permeabilizing concentrations (PC50) of 12, 15,
and 22 mg/ml, respectively. Tigerinin 4 also possesses consid-
erable OM permeabilizing ability. However, the linear analog
of tigerinin 1 (i.e. S-acetamido protected derivative) did not
exhibit antimicrobial activity and also did not permeabilize the
OM of E. coli. Hence, the S-S bridge appears to be essential for
activity.
To determine whether tigerinins are capable of permeabiliz-
ing the inner (cytoplasmic) membrane (IM) of E. coli, the influx
of the chromogenic substrate of the cytoplasmic enzyme b-ga-
lactosidase, ONPG in the absence and presence of the peptides
was monitored. The data is presented in Fig. 5A. It is evident
that tigerinins permeabilize the IM of E. coli effectively. As
tigerinin 2 is the most effective, among tigerinins, in perme-
abilizing the IM of E. coli, the effect of stabilizing the OM with
Ca21 (33) on its IM permeabilizing ability was also investi-
gated. The results are shown in Fig. 5B. Ca21, at a concentra-
tion of 600 mM, almost completely inhibited IM permeabiliza-
tion by tigerinin. Tigerinins are thus unable to permeabilize a
stabilized OM, suggesting that OM permeabilization is an es-
sential and critical step for its activity.
Conformation of Peptides—The CD spectra of tigerinins 1–4
in buffer are shown in Fig. 6. All the peptides show a minimum
;204 nm with crossover at wavelengths ,195 nm. The spectra
indicate a population of unordered and b-turn conformations
(34). The conformations of tigerinins 1, 2, and 3 were analyzed
by theoretical methods involving energy minimization and Mo-
lecular Dynamics Simulations. Comparison of the structures
are shown in Fig. 7. The dihedral angles of the structures
obtained after 500 ps Molecular Dynamics Simulations for both
the peptides with those documented for standard b-turn types
(35) indicate that although b-turn structures are observed for
tigerinin 1, 2, and 3, they are not of type I, II, or III and can be
categorized as type IV.
DISCUSSION
We have described the purification and characterization of
two novel 12-residue peptides and a 11-residue peptide, with
broad-spectrum antimicrobial activity, from the skin secretions
of R. tigerina. The susceptible microorganisms include Gram-
positive and Gram-negative bacteria as well as yeast with
minimal inhibitory concentrations in the range of 30 to 100
mg/ml. These three peptides exhibit high homology among
themselves, with COOH-terminal amidation and a disulfide
bridge between two cysteine residues to form a nonapeptide
ring but are not related to any described previously antimicro-
bial peptides from amphibians. Extensive homology searches
from the protein data banks did not yield any other peptide
homologous to these peptides. These three peptides were also
obtained from the skin extracts of R. tigerina. An additional
peptide of 11 residues which lacked the COOH-terminal Tyr in
tigerinin 3, but marginally less active than tigerinin 3 on all
the organisms tested, was also obtained from the skin extracts.
None of the peptides exhibited any hemolytic activity up to a
concentration of 200 mg/ml. Tigerinins with 11 and 12 residues
are the smallest antimicrobial peptides characterized from am-
phibians and are different from temporins which are linear
peptides with 13 residues (15).
A large number of antimicrobial peptides have been charac-
terized from skin tissue of amphibians (10–14). In the genus
Rana itself peptides belonging to eight families based on their
structural similarities, have been described. These are breve-
nin 1 and 2, esculentin 1 and 2, ranatuerins 1 and 2, ranalexin,
and temporins (15, 36–41). Of these, the first seven families of
peptides are all characterized by a highly basic, heptapeptide
FIG. 6. Circular dichroism spectra
of tigerinins 1, 2, 3, and 4 in 5 mM
HEPES buffer (pH 7.4). Peptide concen-
tration 5 60 mM.
FIG. 7. Structures of tigerinins after molecular dynamics sim-
ulations. Side chains of cationic residues are indicated in red and
hydrophobic residues in blue. Backbone structure is depicted as green
ribbons. Cysteine side chains are in yellow.
Antimicrobial Peptides from Amphibians 2705
 by guest, on Novem
ber 20, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
loop linked by a disulfide bridge at the COOH-terminal end,
but with a highly variable sequence and length at the NH2-
terminal end. However, the presence of the disulfide bridge
does not appear to be critical either for activity or for structure
in the case of Rana peptides identified so far (42–45). The
primary structures of tigerinins are compared with other am-
phibian peptides in Table III which evidently indicates no
sequence homology. It is thus unlikely that tigerinins are de-
rived from similar class of peptides from R. tigerina. All the
amphibian antimicrobial peptides, including the Rana pep-
tides, known thus far, are known to adopt helical structure (15,
36–41). Conformational analysis by CD and theoretical meth-
ods suggest b-turn conformations for tigerinins and these rep-
resent the first examples of nonhelical amphibian antimicro-
bial peptides. A majority of cationic antimicrobial peptides (1,
6, 12, 13), including amphibian skin peptides like magainin
(16) and dermaseptins (17, 18), are known to exert their anti-
microbial activity by permeabilizing the cytoplasmic mem-
brane. Despite being structurally distinct from other amphib-
ian antimicrobial peptides, tigerinins also are capable of
permeabilizing bacterial membranes. While it is conceivable
that tigerinins also exert their antimicrobial activity by perme-
abilizing the microbial membranes, other mechanisms cannot
be ruled out. Indolicidin, a 13-residue Trp-rich antimicrobial
peptide from bovine neutrophils, which is known to permeabi-
lize the outer and cytoplasmic membranes of E. coli also pref-
erentially inhibits synthesis of DNA leading to filamentation of
cells (46). This later mechanism appears to contribute to its
antimicrobial activity. Recently, many other cationic antimi-
crobial peptides have been proposed to kill bacteria by alter-
nate mechanisms (47). Like all other amphibian antimicrobial
peptides (10–14), tigerinins are also cationic (Table III). All of
them carry a charge of 12 with 1 Arg residue and amidated
COOH-terminal end. This low cationicity appears to be suffi-
cient for its biological activity. Earlier we have shown that SPF,
a 13-residue synthetic peptide corresponding to the most hy-
drophobic region of bovine seminal plasmin, with a charge of
11, has both antimicrobial and hemolytic activity (31). Apart
from brevinins, another antimicrobial peptide, with a single
disulfide bond, that is well characterized is thanatin from the
hemipteran insect Podisus maculiventus. Thanatin is a 21-
residue peptide with 50% homology to brevinins (48). However,
in contrast to a heptapeptide loop at the COOH-terminal end of
brevenins, thanatin has an eight-membered ring. Despite the
homology, the secondary structure and mechanism of action
differs from that of brevenin. Thanatin appears to assume a
b-turn structure stabilized by a disulfide bond and is suggested
to exert its action by a nonpore forming mechanism.
The only other short antibacterial peptide with a similar
nonapeptide disulfide linkage is bactenecin which has been
isolated from bovine neutrophils (49). However, bactenecin has
4 arginine residues as compared with one in tigerinins and
therefore considerably more cationic. Reduction of the single
disulfide bond in bactenecin was observed to result in a drastic
change in the antibacterial spectrum (50). The reduced bacte-
necin showed high selectivity for Gram-positive bacteria with
little activity against Gram-negative bacteria whereas native
bactenecin was more active against Gram-negative bacteria. In
tigerinin, absence of disulfide bridge resulted in loss of anti-
bacterial activity indicating the importance of disulfide bridge
for activity. It is very unlikely that tigerinins are related to
bactenecins.
Thus, this paper describes a family of short and nonhelical
antimicrobial peptides in amphibians. As short peptides have
the obvious advantage of easy chemical synthesis, the new
structural motif observed in tigerinins would be easily amena-
ble for the synthesis of analogs with improved activity and
conceivably useful against multidrug-resistant microbes. We
are currently investigating other pharmacological activities of
peptides from the skin secretions of Rana tigerina.
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